Use of complete eluted peptide sequence data from HLA-DR and -DQ molecules to predict T cell epitopes, and the influence of the nonbinding terminal regions of ligands in epitope selection

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 850-858

  Godkin, Andrew J ^a,b   Davenport, Miles P ^a   Willis, Anthony ^c   Jewell, Derek P ^b   Hill, Adrian V S ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

^c MRC Immunochemistry Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE ANTIGEN;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPUTER PROGRAM; HLA SYSTEM; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; EPITOPES, T-LYMPHOCYTE; GLIADIN; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROTEIN BINDING; SOFTWARE;

EID: 0032528495     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Margalit, H., J. Spouge, J. Cornette, K. Cease, C. Delisi, and J. Berzofsky. 1987. Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J. Immunol. 7:2213.
2. Rothbard, J., and W. Taylor. 1988. A sequence pattern common to T-cell epitopes. EMBO J. 7:93.
3. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-J. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
4. Pamer, E., J. Harty, and M. Bevan. 1991. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature 353:852.
5. Hill, A., J. Elvin, A. Willis, M. Aidoo, C. Allsopp, F. Gotch, X. Gao, M. Takiguchi, B. Greenwood, A. Townsend, A. McMichael, and H. Whittle. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434.
6. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
7. Rammensee, H.-G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85.
8. Stern, L., J. Brown, T. Jardetzky, J. Gorga, R. Urban, J. Strominger, and D. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
9. Ghosh, P., M. Amaya, E. Mellins, and D. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
10. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1994. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230.
11. Davenport, M., I. Ho Shon, and A. Hill. 1995. An empirical method for the prediction of T-cell epitopes. Immunogenetics 42:392.
12. Sollid, L., and E. Thorsby. 1995 HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105:910.
13. Shewry, P., J. Napier, and A. Tathem. 1995. Seed storage proteins: structures and biosynthesis. Plant Cell 7:945.
14. Johansen, B., F. Vartdal, J. Eriksen, E. Thorsby, and L. Sollid. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177.
15. Godkin, A., T. Friede, M. Davenport, S. Stevanovic, A. Willis, J. Jewell, A. Hill, and H.-G. Rammensee. 1997. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2). Int. Immunol. 9:905.
16. Robbins, P., E. Evans, A. Ding, N. Warner, and F. Brodsky. 1987. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum. Immunol. 18:301.
17. Shookster, L., T. Matsuyama, and R. Wichester. 1987. Monoclonal antibody Ia3 recognizes a monomorphic epitope unique to DQ molecules. Hum. Immunol. 20:59.
18. Geluk, A., M. K Van, A. A. Janson, J. W. Drijfhout, R. H. Meloen, V. R. De, and T. H. Ottenhoff. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149:2864.
19. Chicz, R., R. Urban, J. Gorga, D. Vignali, W. Lane, and J. Strominger. 1993. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:27.
20. Wucherpfennig, K., A. Sette, S. Southwood, C. Oseroff, M. Matsui, J. Strominger, and D. Hafler. 1994. Structural requirements for binding of an immunodominant myelin basic peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:279.
21. Malcherek, G., K. Falk, O. Rotzschke, H. G. Rammensee, S. Stevanovic, V. Gnau, G. Jung, and A. Melms. 1993. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 5:1229.
22. Mantzaris, G., and D. Jewell. 1991. In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. Scand. J. Gastroenterol. 26:392.
23. Johansen, B., S. Buus, F. Vartdal, H. Viken, J. Eriksen, E. Thorsby, and L. Sollid. 1994. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α 1*0501, β 1*0201) molecule. Int. Immunol. 6:453.
24. ras (Gln to Leu61). Int. Immunol. 4:1331.
25. Chicz, R., W. Lane, R. Robinson, M. Trucco, J. Strominger, and J. Gorga. 1994. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. Int. Immunol. 6:1639.
26. Kasarda, D., T. Okita, J. Bernardin, P. Baecker, C. Nimmo, E. Lew, M. Dietler, and F. Greene. 1984. Nucleic acid (cDNA) and amino acid sequences of α-type gliadins from wheat (Triticum aestivum). Proc. Natl. Acad. Sci. USA 81:4712.
27. Howdle P, ed. 1995. Bailliere's Clinical Gastroenterology, Vol 9: Coeliac disease. Bailliere Tindall, London.
28. Sant'Angelo, D., G. Waterbury, P. Preston-Hurlburt, S. Yoon, R. Medzhitov, S.-C. Hong, and C. Janeway. Jr. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 4:367.
29. Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, F. Chisari, and F. Fiaccadori. 1991. Identification of immunodominant T-cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:214.
30. Hemmer, B., B. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K.-H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T-cell clone. J. Exp. Med. 185:1651.
31. Johansen, B., H. Gjertsen, F. Vartdal, S. Buus, E. Thorsby, K. Lundin, and L. Sollid. 1996. Binding of peptides from the N-terminal region of α-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T-cell assays. Clin. Immunol. Immunopathol. 79:288.
32. Kagnoff, M., R. Austin, J. Hubert, J. Bernardin, and D. Kasarda. 1984. Possible role for a human adenovirus in the pathogenesis of celiac disease. J. Exp. Med. 160:1544.
33. Kagnoff, M., Y. Paterson, P. Kumar, D. Kasarda, F. Carbone, D. Unsworth, and R. Austin. 1987. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 28:995.
34. Lahdeaho, M.-L., P. Parkkonen, T. Reunala, M. Maki, and M. Lehtinen. 1993. Antibodies to E1B protein derived peptides of enteric adenovirus type 40 are associated with celiac disease and dermatitis herpetiformis. Clin. Immunol. Immunopathol. 69:300.
35. Karagiannis, J., J. Priddle, and D. Jewell. 1987. Cell-mediated immunity to a synthetic gliadin peptide resembling a sequence from adenovirus 12. Lancet 1:884.
36. Mantzaris, G., J. Karagiannis, J. Priddle, and D. Jewell. 1990. Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease. Gut 31:668.
37. Sturgess, R., P. Day, H. J. Ellis, K. E. Lundin, H. A. Gjertsen, M. Kontakou, and P. J. Ciclitira. 1994. Wheat peptide challenge in coeliac disease. Lancet 343:758.